Novateor Research Laboratories Limited has announced the launch of a new oral care product as part of its forward integration strategy. The company informed BSE Limited about this development through a regulatory filing on February 11, 2026.

Product Launch Details

The company launched SmiloShine Aligner and Denture Cleaner and Whitener Foam on February 10, 2026. This announcement was made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015.

Strategic Positioning

The launch represents a forward integration step for Novateor Research Laboratories Limited, expanding its product portfolio in the oral care segment. The product is specifically designed for aligner and denture cleaning and whitening applications, targeting both domestic and international markets.

Company Information

Novateor Research Laboratories Limited operates in the cosmetic and pharmaceutical products sector. The company is listed on BSE with script code 542771 and has its registered office in Ahmedabad, Gujarat. The announcement was signed by Navdeep Mehta, Managing Director of the company.

Market Reach

The SmiloShine product line is positioned to serve customers across domestic and international markets, indicating the company's expansion strategy beyond local boundaries. The product launch aligns with the company's focus on innovative cosmetic and pharmaceutical products.

Novateor Research Laboratories Limited has announced a significant change in its key managerial personnel. The company has appointed Mrs. Pooja Bafna Rathi as its new Company Secretary cum Compliance Officer, effective November 3, 2025.

Key Details of the Appointment

Professional Background

Mrs. Rathi brings a diverse educational background to her new role:

• Associate Company Secretary (ACS)
• UGC-NET qualified
• Bachelor of Laws (LLB)
• Bachelor of Education (B.Ed)
• Central Teacher Eligibility Test (CTET) qualified
• Master of Commerce in Business Policy and Corporate Governance [M.Com (BP&CG)]

This appointment is in compliance with Section 203 of the Companies Act, 2013, and Regulation 6(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Implications for Novateor Research Laboratories

The appointment of Mrs. Rathi as Company Secretary and Compliance Officer is a crucial move for Novateor Research Laboratories Limited. In this role, she will be responsible for ensuring the company's adherence to regulatory requirements and maintaining effective corporate governance practices.

It's worth noting that as of the appointment date, Mrs. Rathi holds no shares in the company, as disclosed in the official communication.

This strategic appointment underscores Novateor Research Laboratories' commitment to maintaining strong corporate governance and regulatory compliance. Mrs. Rathi's diverse qualifications and expertise are expected to contribute significantly to the company's administrative and compliance functions.